Introduction to Bladder Cancer Type and Therapy
Bladder cancer is a heterogeneous disease with a variable natural history. 70% present with NMI tumours (stages Ta, T1, or carcinoma in situ) (Sun and Trinh in Hematol Oncol Clin North Am 29(2):205–18, 2015). 30% present with muscle-invasive disease (T2–4) associated with a high risk of death from distant metastases (Sun and Trinh in Hematol Oncol Clin North Am 29(2):205–18, 2015). This chapter covers introduction to bladder cancer type and therapy.